Haraoui B - Search Results

1

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial.

Tak PP, Mease PJ, Genovese MC, Kremer J, Haraoui B, Tanaka Y, Bingham CO 3rd, Ashrafzadeh A, Travers H, Safa-Leathers S, Kumar S, Dummer W. Tak PP, et al. Among authors: haraoui b. Arthritis Rheum. 2012 Feb;64(2):360-70. doi: 10.1002/art.33353. Arthritis Rheum. 2012. PMID: 22389919 Free article. Clinical Trial.

2

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial.

Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG, et al. Carette S, et al. Among authors: haraoui b. Arthritis Rheum. 1994 Jan;37(1):32-40. doi: 10.1002/art.1780370106. Arthritis Rheum. 1994. PMID: 8129762 Clinical Trial.

3

The incidence of cancer associated with the treatment of rheumatoid arthritis.

Beauparlant P, Papp K, Haraoui B. Beauparlant P, et al. Among authors: haraoui b. Semin Arthritis Rheum. 1999 Dec;29(3):148-58. doi: 10.1016/s0049-0172(99)80026-2. Semin Arthritis Rheum. 1999. PMID: 10622679

4

Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group.

Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, Wigler I, Rosner IA, Beaulieu AD. Pelletier JP, et al. Among authors: haraoui b. Arthritis Rheum. 2000 Oct;43(10):2339-48. doi: 10.1002/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P. Arthritis Rheum. 2000. PMID: 11037895 Free article. Clinical Trial.

5

Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.

Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, Uthman I, Khy V, Tremblay JL, Bertrand C, Pelletier JP. Raynauld JP, et al. Among authors: haraoui b. Arthritis Rheum. 2003 Feb;48(2):370-7. doi: 10.1002/art.10777. Arthritis Rheum. 2003. PMID: 12571845 Free article. Clinical Trial.

6

Differentiating the efficacy of tumor necrosis factor inhibitors.

Haraoui B. Haraoui B. J Rheumatol Suppl. 2005 Mar;74:3-7. J Rheumatol Suppl. 2005. PMID: 15742457 Review.

7

Differentiating the efficacy of the tumor necrosis factor inhibitors.

Haraoui B. Haraoui B. Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):7-11. doi: 10.1016/j.semarthrit.2005.01.003. Semin Arthritis Rheum. 2005. PMID: 15852248 Review.

8

Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action.

Haraoui B, Krelenbaum M. Haraoui B, et al. Semin Arthritis Rheum. 2009 Dec;39(3):176-81. doi: 10.1016/j.semarthrit.2008.06.004. Epub 2008 Aug 15. Semin Arthritis Rheum. 2009. PMID: 18706681

9

Effectiveness and safety of etanercept in subjects with RA who have failed infliximab therapy: 16-week, open-label, observational study.

Bingham CO 3rd, Ince A, Haraoui B, Keystone EC, Chon Y, Baumgartner S. Bingham CO 3rd, et al. Among authors: haraoui b. Curr Med Res Opin. 2009 May;25(5):1131-42. doi: 10.1185/03007990902841010. Curr Med Res Opin. 2009. PMID: 19317607 Clinical Trial.

10

Treatment of early rheumatoid arthritis: concepts in management.

Haraoui B, Pope J. Haraoui B, et al. Semin Arthritis Rheum. 2011 Apr;40(5):371-88. doi: 10.1016/j.semarthrit.2010.10.004. Epub 2011 Feb 4. Semin Arthritis Rheum. 2011. PMID: 21295822 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters